OSX strikes agreement for orthopaedic products in Hong Kong
Filed with ASX · · 5 pages · English
Summary by 6ix AI
Osteopore Ltd. has announced an exclusive distribution agreement with MontsMed Hong Kong Company Limited to expand its orthopaedic business into Hong Kong, focusing on trauma reconstruction products. CEO Dr. Yujing Lim expressed enthusiasm about the partnership, emphasizing the potential for Osteopore's innovative products in the local market.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Osteopore
- Clarification - OSX partner Chinese dental & maxillofacial
- OSX partners up for Chinese dental & maxillofacial market
- OSX partners DKSH for dental products in Malaysia
- Activities Report September 2025 and Appendix 4C
- OSX collaborates with TTSH to develop novel implant for AVN
Later from Osteopore
- Clarification - agreement for orthopaedic products in HK
- Activities Report December 2025 and Appendix 4C
- Further Drawdown of T1 of the Redeemable Convertible Notes
- Osteopore Secures Latin America Deal For Craniofacial Distribution
- OSX secures Latin America deal for craniofacial distribution
Follow Osteopore into a list and get an email when it puts out news.
Follow Osteopore